- 全部删除
您的购物车当前为空
Crinecerfont (SSR-125543) 是促肾上腺皮质激素释放因子 1 受体 (CRF1) 的特异性拮抗剂,可用于经典先天性肾上腺增生的研究。

Crinecerfont (SSR-125543) 是促肾上腺皮质激素释放因子 1 受体 (CRF1) 的特异性拮抗剂,可用于经典先天性肾上腺增生的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 645 | In stock | |
| 5 mg | ¥ 1,290 | In stock | |
| 10 mg | ¥ 2,070 | In stock | |
| 25 mg | ¥ 4,130 | In stock |
Crinecerfont 相关产品
| 产品描述 | Crinecerfont (SSR-125543) is a selective antagonist of corticotropin-releasing factor 1 receptor (CRF1) and can be used in studies about Classic congenital adrenal hyperplasia. |
| 别名 | SSR-125543A, SSR125543A, SSR-125543, SSR125543, SSR 125543A, SSR 125543 |
| 分子量 | 483.04 |
| 分子式 | C27H28ClFN2OS |
| CAS No. | 752253-39-7 |
| Smiles | [C@H](N(CC#C)C1=NC(=C(C)S1)C2=C(Cl)C=C(OC)C(C)=C2)(CC3CC3)C4=CC(F)=C(C)C=C4 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 45 mg/mL (93.16 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容